Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Misaki, Homma"'
Publikováno v:
SLAS Discovery, Vol 28, Iss 7, Pp 344-349 (2023)
The beta-glucocerebrosidase (GBA1) gene encodes the lysosomal beta-glucocerebrosidase (GCase) that metabolizes the lipids glucosylceramide (GlcCer) and glucosylsphingosine (GlcSph). Biallelic loss-of-function mutations in GBA1 such as L444P cause Gau
Externí odkaz:
https://doaj.org/article/6fa5022fc3904bd99b6d9e7cc05d8004
Autor:
Toshiyuki Nomura, Hiroshi Sugimoto, Noriko Uchiyama, Akihiro Ohashi, Hideto Hara, Takashi Imada, Yukiko Yamamoto, Isaac Hoffman, Kenichi Iwai, Momoko Ohori, Misaki Homma, Osamu Kurasawa, Nobuo Cho, Tohru Miyazaki, Yuya Oguro, Kentaro Iwata, Robert J. Skene
Publikováno v:
Journal of Medicinal Chemistry. 63:1084-1104
In our pursuit of developing a novel, potent, and selective cell division cycle 7 (Cdc7) inhibitor, we optimized the previously reported thieno[3,2-d]pyrimidinone analogue I showing time-dependent Cdc7 kinase inhibition and slow dissociation kinetics
Autor:
Osamu, Kurasawa, Tohru, Miyazaki, Misaki, Homma, Yuya, Oguro, Takashi, Imada, Noriko, Uchiyama, Kenichi, Iwai, Yukiko, Yamamoto, Momoko, Ohori, Hideto, Hara, Hiroshi, Sugimoto, Kentaro, Iwata, Robert, Skene, Isaac, Hoffman, Akihiro, Ohashi, Toshiyuki, Nomura, Nobuo, Cho
Publikováno v:
Journal of medicinal chemistry. 63(3)
In our pursuit of developing a novel, potent, and selective cell division cycle 7 (Cdc7) inhibitor, we optimized the previously reported thieno[3,2
Autor:
Hideto Hara, Misaki Homma, Akihiro Ohashi, Yuya Oguro, Kouji Mori, Osamu Kurasawa, Nobuo Cho, Tohru Miyazaki, Sei Yoshida, Kenichi Iwai, Noriko Uchiyama
Publikováno v:
Bioorganic & Medicinal Chemistry. 25:3658-3670
In order to increase the success rate for developing new Cdc7 inhibitors for cancer therapy, we explored a new chemotype which can comply with the previously-constructed pharmacophore model. Substitution of a pyridine ring of a serendipitously-identi
Autor:
Misaki Homma, Shunsuke Ebara, Jie Yu, Sachio Shibata, Ryosuke Hibino, Akifumi Kogame, Satoru Nishizawa, Takashi Imada, Yukiko Yamamoto, Akihiro Ohashi, Huifeng Niu, Kazunori Yamanaka, Nobuo Cho, Tohru Miyazaki, Masamitsu Gotou, Kenichi Iwai, Kristin E. Burke, Momoko Ohori, Tadahiro Nambu, Toshiyuki Takeuchi, Osamu Kurasawa, Ryo Dairiki, Noriko Uchiyama, Yuya Oguro
Publikováno v:
Science Advances
A next generation cancer drug candidate, a CDC7 inhibitor, TAK-931, was developed, which is being evaluated in clinical trials.
Replication stress (RS) is a cancer hallmark; chemotherapeutic drugs targeting RS are widely used as treatments for v
Replication stress (RS) is a cancer hallmark; chemotherapeutic drugs targeting RS are widely used as treatments for v
Autor:
Hiroshi Hama, Yoko Ishida, Mayu Sugiyama, Hiroyuki Hioki, Hiroyuki Katayama, Yoshiyuki Tsujihata, Masaaki Funata, Koji Nagasawa, Megumu Takahashi, Ryoko Ando, Takanori Nishimura, Nobuyo Yoshida, Misaki Homma, Hiroshi Kurokawa, Atsushi Miyawaki
Publikováno v:
Cell. 181:1176-1187.e16
Dysfunctional mitochondria accumulate in many human diseases. Accordingly, mitophagy, which removes these mitochondria through lysosomal degradation, is attracting broad attention. Due to uncertainties in the operational principles of conventional mi
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 24:5836-5839
Identification of inhibitors for protein-protein interactions (PPIs) from high-throughput screening (HTS) is challenging due to the weak affinity of primary hits. We present a hit validation strategy of PPI inhibitors using quantitative ligand displa
Autor:
Isaac Hoffman, Sei Yoshida, Osamu Kurasawa, Kenichi Iwai, Tomoyasu Ishikawa, Kouji Mori, Akihiro Ohashi, Hideto Hara, Nobuo Cho, Tohru Miyazaki, Robert J. Skene, Yuya Oguro, Misaki Homma
Publikováno v:
Bioorganicmedicinal chemistry. 25(7)
Cell division cycle 7 (Cdc7) is a serine/threonine kinase that plays important roles in the regulation of DNA replication process. A genetic study indicates that Cdc7 inhibition can induce selective tumor-cell death in a p53-dependent manner, suggest
Autor:
Yasuhiro Imaeda, Yuta Tanaka, Tomohiro Kawamoto, Ikuo Miyahisa, Katsuji Aikawa, Michiko Tawada, Nobuo Cho, Tomoyasu Ishikawa, Satoshi Sogabe, Tomoya Sameshima, Yumi Imai, Yumi Hayano, Goushi Nishida, Masakazu Inazuka, Misaki Homma, Shigeru Igaki
Publikováno v:
Journal of medicinal chemistry. 56(23)
Mcl-1 and Bcl-xL are crucial regulators of apoptosis, therefore dual inhibitors of both proteins could serve as promising new anticancer drugs. To design Mcl-1/Bcl-xL dual inhibitors, we performed structure-guided analyses of the corresponding select